YI 328-18細胞
是否是腫瘤細胞： 0
物種來源： 小鼠
生長狀態： 懸浮生長
細胞形態： **樣
**類型： IgG3
ATCC Number： HB-9306?
運輸方式： 凍存運輸
數量： 大量
Designations: YI 328-18
Depositors: R Kannagi
YI 328-18細胞Isotype: IgG3
Biosafety Level: 1
Shipped: frozen
Medium & Serum: See Propagation
Growth Properties: suspension
Organism: Mus musculus (B cell); Mus musculus (myeloma)
Morphology: lymphoblast
Cellular Products: immunoglobulin; monoclonal antibody; against glycosphingolipid
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. YI 328-18細胞Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments: Animals were immunized with a synthetic lactoganglioseries glycolipid.
Spleen cells were fused with P3X63Ag8U.1 mouse myeloma cells.
Both YI328-18 (ATCC HB-9306)and YI328-51 (ATCC HB-9307) specifically recognize the abnormal branching structure of the lactoganglioseries glycolipid antigen molecule and have almost no cross-reactivity with smaller unbranched segments.
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Temperature: 37.0°C
Subculturing: Medium Renewal: Every 2 days
YI 328-18細胞Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 to 2 X 10 exp5 viable cells/ml.
Maintain cell density between 1 X 10 exp5 and 1 X 10 exp6 viable cells/ml.
Preservation: Freeze medium: complete growth medium supplemented with an additional 10% fetal bovine serum and 10% (v/v) DMSO.
Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
recommended serum:ATCC 30-2020
References: 44223: Kannagi R, et al. YI 328-18細胞Monoclonal antibodies specific for synthetic glycosphingolipids having abnormal branched structure. US Patent 4,885,358 dated Dec 5 1989
